loader image
Saturday, February 22, 2025
38 F
McAllen
We Welcome your Press Release
- Advertisement -

Harlingen Medical Center & Texas State Technical College Team Up to Raise Awareness for Celiac Disease

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

About the Event

Harlingen Medical Center (HMC) & Texas State Technical College (TSTC) are teaming up to promote health and wellness and raise awareness of Celiac Disease – with the first HMC & TSTC Celiac Disease Awareness 5k Run/1m Walk.  The goal with the run-walk is to bring education to the residents of South Texas regarding the health-related risks linked to celiac disease, which is a genetic autoimmune disorder where the ingestion of gluten leads to possible damage in the small intestine.

The Run/Walk

- Advertisement -

The Run-Walk is OPEN TO THE COMMUNITY!  It will feature complimentary basic medical screenings, health and wellness education, a Zumba-warm-up session prior to the run/walk, an Education Expo with demonstrations on healthy meal preparation, gluten-free food options, education on celiac disease, Doc Talk Lectures featuring expert presentations on healthy-living, fun activities for young children, and much more! 

Registration is NOW OPEN

To register as a participant of the Run-Walk, you may do so by downloading the attached Participant Registration Form and returning to the Marketing Office at Harlingen Medical Center (located inside the Administration Offices), with payment; or, you may register on-line at:https://www.eventbrite.com/e/harlingen-medical-center-tstc-1st-annual-celiac-disease-awareness-run-walk-tickets-33446274708.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×